AR
Adam R Kalbermatten bought $101K of KRMD stock
Adam R Kalbermatten, Chief Commercial Officer of KORU Medical Systems, Inc. (KRMD), bought 32,000 shares of KRMD stock worth $101K, per an SEC Form 4 filed Sep 9, 2026.
It was an open-market purchase.
The trade happened on Sep 8, 2026, 1 day before it was made public.
KRMD has moved -2.5% since the trade date, from $3.17 to $3.09 (Nov 6, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 1 day
- Price since
- -2.5%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4